Annual report
7681.TEDINET S100PU2R
Period2021-10-01 → 2022-09-30
Filed2022-12-22
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 154
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥29.8bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥26.3bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales |
| Revenue | ¥22.0bn | 2019-10-01 → 2020-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.1bn | 2018-10-01 → 2019-09-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥25.7bn | 2017-10-01 → 2018-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥651m | 2021-10-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥576m | 2020-10-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥710m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥596m | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥207m | 2019-10-01 → 2020-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2018-10-01 → 2019-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥652m | 2017-10-01 → 2018-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥690m | 2021-10-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥595m | 2020-10-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥437m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥391m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥121m | 2019-10-01 → 2020-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥733m | 2018-10-01 → 2019-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥358m | 2017-10-01 → 2018-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥471m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥410m | 2020-10-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥13.0bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥13.4bn | at 2020-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.8bn | at 2019-09-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥12.9bn | at 2018-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.9bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥7.8bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.5bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥4.8bn | at 2020-09-30d | Cons. | Net assets |
| Net assets / equity | ¥4.3bn | at 2019-09-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.7bn | at 2018-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.4bn | at 2021-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.4bn | at 2020-09-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.2bn | at 2019-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.7bn | at 2018-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥242m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥1.9bn | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.8bn | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥963m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥50m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥42m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥64m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥92m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥53m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥121m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥298m | 2020-10-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥238m | 2019-10-01 → 2020-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥213m | 2018-10-01 → 2019-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥203m | 2017-10-01 → 2018-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥222.9 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥199.92 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥62.51 | 2019-10-01 → 2020-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥411.31 | 2018-10-01 → 2019-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥323.64 | 2017-10-01 → 2018-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥221.52 | 2021-10-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥198.33 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.85 | 2019-10-01 → 2020-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥2,746.25 | at 2022-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,567.33 | at 2021-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,408.78 | at 2020-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,376.58 | at 2019-09-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥2,016.04 | at 2018-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 40.0% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.8% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2020-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2019-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 27.9% | at 2018-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2021-10-01 → 2022-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.0% | 2020-10-01 → 2021-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.7% | 2019-10-01 → 2020-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 18.7% | 2018-10-01 → 2019-09-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2017-10-01 → 2018-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 175 | at 2022-09-30 | Cons. | Number of employees |
| Employees | 162 | at 2021-09-30 | Cons. | Number of employees |
| Employees | 157 | at 2020-09-30d | Cons. | Number of employees |
| Employees | 155 | at 2019-09-30d | Cons. | Number of employees |
| Employees | 153 | at 2018-09-30d | Cons. | Number of employees |
| Revenue | ¥27.3bn | 2021-10-01 → 2022-09-30 | Standalone | Net sales |
| Revenue | ¥23.4bn | 2020-10-01 → 2021-09-30 | Standalone | Net sales |
| Revenue | ¥19.7bn | 2019-10-01 → 2020-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥32.8bn | 2018-10-01 → 2019-09-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥23.4bn | 2017-10-01 → 2018-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥420m | 2021-10-01 → 2022-09-30 | Standalone | Operating income |
| Operating income | ¥398m | 2020-10-01 → 2021-09-30 | Standalone | Operating income |
| Ordinary income | ¥448m | 2021-10-01 → 2022-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥435m | 2020-10-01 → 2021-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥234m | 2019-10-01 → 2020-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2018-10-01 → 2019-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥707m | 2017-10-01 → 2018-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥428m | 2021-10-01 → 2022-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥435m | 2020-10-01 → 2021-09-30 | Standalone | Income before income taxes |
| Net income | ¥294m | 2021-10-01 → 2022-09-30 | Standalone | Profit loss |
| Net income | ¥297m | 2020-10-01 → 2021-09-30 | Standalone | Profit loss |
| Net income | ¥194m | 2019-10-01 → 2020-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥704m | 2018-10-01 → 2019-09-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥476m | 2017-10-01 → 2018-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥12.3bn | at 2022-09-30 | Standalone | Assets |
| Total assets | ¥11.8bn | at 2021-09-30 | Standalone | Assets |
| Total assets | ¥12.7bn | at 2020-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥11.8bn | at 2019-09-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.0bn | at 2018-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥7.2bn | at 2022-09-30 | Standalone | Liabilities |
| Total liabilities | ¥7.0bn | at 2021-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥5.0bn | at 2022-09-30 | Standalone | Net assets |
| Net assets / equity | ¥4.8bn | at 2021-09-30 | Standalone | Net assets |
| Net assets / equity | ¥4.6bn | at 2020-09-30d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2019-09-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.4bn | at 2018-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.5bn | at 2022-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.6bn | at 2021-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥149.72 | 2021-10-01 → 2022-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥151.61 | 2020-10-01 → 2021-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥100.58 | 2019-10-01 → 2020-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥394.83 | 2018-10-01 → 2019-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥430.72 | 2017-10-01 → 2018-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥148.79 | 2021-10-01 → 2022-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥150.41 | 2020-10-01 → 2021-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥99.53 | 2019-10-01 → 2020-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥50 | 2021-10-01 → 2022-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2020-10-01 → 2021-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-10-01 → 2020-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-10-01 → 2019-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2017-10-01 → 2018-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,560.72 | at 2022-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,454.98 | at 2021-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,344.4 | at 2020-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,264.68 | at 2019-09-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,920.63 | at 2018-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 40.9% | at 2022-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.9% | at 2021-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.2% | at 2020-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2019-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.4% | at 2018-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.0% | 2021-10-01 → 2022-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2020-10-01 → 2021-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.5% | 2019-10-01 → 2020-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 18.9% | 2018-10-01 → 2019-09-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.0% | 2017-10-01 → 2018-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,960,800 | at 2022-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,960,800 | at 2021-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,954,400 | at 2020-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,784,000 | at 2019-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,784,000 | at 2018-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 134 | at 2022-09-30 | Standalone | Number of employees |
| Employees | 118 | at 2021-09-30 | Standalone | Number of employees |
| Employees | 114 | at 2020-09-30d | Standalone | Number of employees |
| Employees | 107 | at 2019-09-30d | Standalone | Number of employees |
| Employees | 105 | at 2018-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | depreciation | 2021-10-01 → 2022-09-30 | −¥26,000 |
| Reconciling Itemsreconciling | segment assets | at 2022-09-30 | −¥146m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-09-30 | ¥3m |
| Food Servicereportable segment | capex | 2021-10-01 → 2022-09-30 | ¥10m |
| Food Servicereportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥7m |
| Food Servicereportable segment | employees | at 2022-09-30 | 16 pure |
| Food Servicereportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥403m |
| Food Servicereportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥403m |
| Food Servicereportable segment | segment assets | at 2022-09-30 | ¥180m |
| Food Servicereportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥7m |
| Remote Image Diagnosis Service Businessreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥4m |
| Remote Image Diagnosis Service Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥10m |
| Remote Image Diagnosis Service Businessreportable segment | employees | at 2022-09-30 | 14 pure |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥676m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥676m |
| Remote Image Diagnosis Service Businessreportable segment | segment assets | at 2022-09-30 | ¥559m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥67m |
| Total Medical Solution Businessreportable segment | capex | 2021-10-01 → 2022-09-30 | ¥43m |
| Total Medical Solution Businessreportable segment | depreciation | 2021-10-01 → 2022-09-30 | ¥79m |
| Total Medical Solution Businessreportable segment | employees | at 2022-09-30 | 145 pure |
| Total Medical Solution Businessreportable segment | revenue | 2021-10-01 → 2022-09-30 | ¥28.7bn |
| Total Medical Solution Businessreportable segment | revenue external | 2021-10-01 → 2022-09-30 | ¥28.7bn |
| Total Medical Solution Businessreportable segment | segment assets | at 2022-09-30 | ¥12.9bn |
| Total Medical Solution Businessreportable segment | segment profit | 2021-10-01 → 2022-09-30 | ¥574m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-10-01 → 2022-09-30 | ¥57m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-10-01 → 2022-09-30 | ¥96m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-10-01 → 2022-09-30 | ¥29.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-10-01 → 2022-09-30 | ¥29.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-09-30 | ¥13.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-10-01 → 2022-09-30 | ¥648m |
| Reconciling Itemsreconciling | depreciation | 2020-10-01 → 2021-09-30 | −¥147,000 |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-09-30 | −¥128,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-09-30 | −¥128,000 |
| Reconciling Itemsreconciling | segment assets | at 2021-09-30 | −¥146m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-09-30 | ¥3m |
| Food Servicereportable segment | capex | 2020-10-01 → 2021-09-30 | ¥10m |
| Food Servicereportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥6m |
| Food Servicereportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥464m |
| Food Servicereportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥464m |
| Food Servicereportable segment | segment assets | at 2021-09-30 | ¥184m |
| Food Servicereportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥37m |
| Remote Image Diagnosis Service Businessreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥10m |
| Remote Image Diagnosis Service Businessreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥14m |
| Remote Image Diagnosis Service Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥647m |
| Remote Image Diagnosis Service Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥647m |
| Remote Image Diagnosis Service Businessreportable segment | segment assets | at 2021-09-30 | ¥461m |
| Remote Image Diagnosis Service Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥73m |
| Total Medical Solution Businessreportable segment | capex | 2020-10-01 → 2021-09-30 | ¥32m |
| Total Medical Solution Businessreportable segment | depreciation | 2020-10-01 → 2021-09-30 | ¥75m |
| Total Medical Solution Businessreportable segment | revenue | 2020-10-01 → 2021-09-30 | ¥25.2bn |
| Total Medical Solution Businessreportable segment | revenue external | 2020-10-01 → 2021-09-30 | ¥25.2bn |
| Total Medical Solution Businessreportable segment | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥128,000 |
| Total Medical Solution Businessreportable segment | segment assets | at 2021-09-30 | ¥12.5bn |
| Total Medical Solution Businessreportable segment | segment profit | 2020-10-01 → 2021-09-30 | ¥464m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-10-01 → 2021-09-30 | ¥52m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-10-01 → 2021-09-30 | ¥95m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-10-01 → 2021-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-10-01 → 2021-09-30 | ¥26.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2020-10-01 → 2021-09-30 | ¥128,000 |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-09-30 | ¥13.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-10-01 → 2021-09-30 | ¥573m |
| Total Medical Solution Businessreportable segment | employees | at 2022-09-30 | 134 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,402
| Item | Context | Value | Unit |
|---|---|---|---|
| Total assets (5-year summary) | CurrentYearInstant | 13468183000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant | 2016.04 | |
| Net assets per share (5-year summary) | Prior3YearInstant | 2376.58 | |
| Net assets per share (5-year summary) | Prior2YearInstant | 2408.78 | |
| Net assets per share (5-year summary) | Prior1YearInstant | 2567.33 | |
| Net assets per share (5-year summary) | CurrentYearInstant | 2746.25 | |
| Basic earnings loss per share (5-year summary) | Prior4YearDuration | 323.64 | |
| Basic earnings loss per share (5-year summary) | Prior3YearDuration | 411.31 | |
| Basic earnings loss per share (5-year summary) | Prior2YearDuration | 62.51 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 199.92 | |
| Basic earnings loss per share (5-year summary) | CurrentYearDuration | 222.90 | |
| Diluted earnings per share (5-year summary) | Prior4YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior3YearDuration | － | |
| Diluted earnings per share (5-year summary) | Prior2YearDuration | 61.85 | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 198.33 | |
| Diluted earnings per share (5-year summary) | CurrentYearDuration | 221.52 | |
| Equity to asset ratio (5-year summary) | Prior4YearInstant | 0.279 | |
| Equity to asset ratio (5-year summary) | Prior3YearInstant | 0.330 | |
| Equity to asset ratio (5-year summary) | Prior2YearInstant | 0.351 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.388 | |
| Equity to asset ratio (5-year summary) | CurrentYearInstant | 0.400 | |
| Rate of return on equity (5-year summary) | Prior4YearDuration | 0.112 | |
| Rate of return on equity (5-year summary) | Prior3YearDuration | 0.187 | |
| Rate of return on equity (5-year summary) | Prior2YearDuration | 0.027 | |
| Rate of return on equity (5-year summary) | Prior1YearDuration | 0.080 | |
| Rate of return on equity (5-year summary) | CurrentYearDuration | 0.084 | |
| Price earnings ratio (5-year summary) | Prior4YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior3YearDuration | － | |
| Price earnings ratio (5-year summary) | Prior2YearDuration | 38.1 | |
| Price earnings ratio (5-year summary) | Prior1YearDuration | 16.1 | |
| Price earnings ratio (5-year summary) | CurrentYearDuration | 10.3 | |
| Net cash provided by used in operating activities (5-year summary) | Prior4YearDuration | 962625000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior3YearDuration | 2764536000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior2YearDuration | -1906273000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1298076000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYearDuration | 242357000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior4YearDuration | -52847000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior3YearDuration | -91784000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior2YearDuration | -63598000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -42129000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | -49958000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 203275000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | -213022000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 238372000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -298007000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -120931000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 3702552000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 6162281000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 4430782000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 5388721000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |